Liminatus Pharma, Inc. Class A Common StockLIMN

$0.12-0.00 (-2.30%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$3M

Micro-cap

-97%

2025 — today

10-Year Price

-96%

2025 — today

52-Week Range

$0.11$26.67

Current $0.12· 0%

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

Valuation in context

P/E ratio

-0.3

N/A

Not meaningful — company is unprofitable

P/B ratio

-21.4

N/A

Not meaningful — company is unprofitable

FCF Yield

-423.5%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when LIMN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.